focus -WSS

focus

author：leisure time 2025-09-28 01:35:42 - browse：21

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Ukrainian soldiers say they owe lives to US

WSS

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

UnitedHealth wins $3.3 billion takeover of Amedisys

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Eating disorder hotline's move to chatbot carried cost for volunteers

hotspot

focus

A Worst CEO gets some much-needed help

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Trump demands the U.S. pay no more for drugs than other countries … again

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

ChatGPT in medicine: STAT answers readers' burning questions

Mississippi candidates for statewide offices square off in party primaries

Trump demands the U.S. pay no more for drugs than other countries … again

Medical experts exlpore how to eliminate bias in clinical algorithms

focus

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Illinois to ban advertising for guns allegedly marketed to kids and militants

Tuskegee Airman Raymond Cassagnol dies at 102

At least 12 people were injured in a blast at a port in northwest Turkey

Illinois to ban advertising for guns allegedly marketed to kids and militants

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

focus

focus

Wikipedia

explore